XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows used in operating activities:    
Net loss $ (11,759) $ (20,749)
Adjustments to reconcile net loss for the period to net cash used in operating activities:    
Non-cash interest expense, including accelerated amortization of original issue discount and issuance costs 2,998 9,615
Depreciation and amortization 534 616
Stock-based compensation 528 679
Asset retirement obligation adjustments and accretion expense 333 2,223
(Gain) loss on sale of equipment, net (57) 132
Miscellaneous gain (122) (1,436)
Changes in operating assets and liabilities:    
Receivables, net 41 1
Supplies inventories, net 41 113
Prepaids and deposits 911 (351)
Accounts payable, accrued expenses, and other liabilities (3,143) (2,576)
Net cash used in operating activities (9,695) (11,733)
Cash flows (used in) provided by investing activities:    
Proceeds from sale of assets 57 270
Additions to property, plant, and equipment (171) (25)
Net cash (used in) provided by investing activities (114) 245
Cash flows provided by (used in) financing activities:    
Proceeds from issuance of common stock 258 1,160
Principal payments (33) (38,023)
Public offering issuance costs (exclusive of accrued amount of $76) (43) 0
Net cash provided by (used in) financing activities 182 (36,863)
Net decrease in cash, cash equivalents, and restricted cash (9,627) (48,351)
Cash, cash equivalents, and restricted cash, beginning of period 77,057 132,550
Cash, cash equivalents, and restricted cash, end of period 67,430 84,199
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 39,688 57,566
Restricted cash 27,742 26,633
Total cash, cash equivalents, and restricted cash $ 67,430 $ 84,199